Psykey, Inc. (CEOS)
USD 0.01
(7.69%)
USD 0.01
(7.69%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -797.5 Thousand USD | -124.15% |
| 2022 | -355.79 Thousand USD | -7.28% |
| 2021 | -331.66 Thousand USD | 0.0% |
| 2020 | - USD | 100.0% |
| 2019 | -4340.00 USD | -494.52% |
| 2018 | -730.00 USD | 0.0% |
| 2016 | -632 Thousand USD | 54.99% |
| 2015 | -1.4 Million USD | -38.44% |
| 2014 | -1.01 Million USD | 0.0% |
| 2007 | 9.54 Million USD | -15.24% |
| 2006 | 11.26 Million USD | 43615.56% |
| 2005 | 25.77 Thousand USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 Q4 | -254.99 Thousand USD | 1.89% |
| 2023 FY | -797.5 Thousand USD | -124.15% |
| 2023 Q3 | -259.9 Thousand USD | -51.01% |
| 2023 Q1 | -110.51 Thousand USD | 0.7% |
| 2023 Q2 | -172.11 Thousand USD | -55.74% |
| 2022 FY | -355.79 Thousand USD | -7.28% |
| 2022 Q3 | -80.58 Thousand USD | 2.93% |
| 2022 Q4 | -111.29 Thousand USD | -38.11% |
| 2022 Q1 | -80.92 Thousand USD | 70.81% |
| 2022 Q2 | -83.01 Thousand USD | -2.58% |
| 2021 Q4 | -277.23 Thousand USD | -905.55% |
| 2021 FY | -331.66 Thousand USD | 0.0% |
| 2021 Q1 | -12.1 Thousand USD | 0.0% |
| 2021 Q2 | -14.76 Thousand USD | -21.98% |
| 2021 Q3 | -27.57 Thousand USD | -86.79% |
| 2020 FY | - USD | 100.0% |
| 2019 FY | -4340.00 USD | -494.52% |
| 2018 FY | -730.00 USD | 0.0% |
| 2016 FY | -632 Thousand USD | 54.99% |
| 2015 FY | -1.4 Million USD | -38.44% |
| 2014 FY | -1.01 Million USD | 0.0% |
| 2008 Q2 | 476.77 Thousand USD | -45.6% |
| 2008 Q3 | 2.24 Million USD | 370.55% |
| 2008 Q1 | 876.34 Thousand USD | -33.56% |
| 2007 Q2 | 2.88 Million USD | 12.61% |
| 2007 Q3 | 2.78 Million USD | -3.22% |
| 2007 Q1 | 2.55 Million USD | -29.08% |
| 2007 Q4 | 1.31 Million USD | -52.71% |
| 2007 FY | 9.54 Million USD | -15.24% |
| 2006 Q3 | 1.92 Million USD | -50.17% |
| 2006 FY | 11.26 Million USD | 43615.56% |
| 2006 Q4 | 3.6 Million USD | 87.63% |
| 2006 Q1 | 1.83 Million USD | 0.0% |
| 2006 Q2 | 3.85 Million USD | 110.76% |
| 2005 FY | 25.77 Thousand USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| American Medical Technologies Inc. | 1.16 Million USD | 168.501% |
| Ansell Limited | 129.3 Million USD | 100.617% |
| Ansell Limited | 129.3 Million USD | 100.617% |
| BG Medicine, Inc. | - USD | Infinity% |
| Biotage AB (publ) | 31.13 Million USD | 102.561% |
| BioLife Sciences Inc. | - USD | Infinity% |
| CB Scientific, Inc. | -1.59 Million USD | 50.022% |
| ConvaTec Group Plc | 262.7 Million USD | 100.304% |
| ConvaTec Group Plc | 262.7 Million USD | 100.304% |
| Encision Inc. | -640.78 Thousand USD | -24.458% |
| Golden Valley Development, Inc | -141.81 Thousand USD | -462.375% |
| Hear AtLast Holdings, Inc. | -109.93 Thousand USD | -625.465% |
| Innovative MedTech Inc. | -4.27 Million USD | 81.341% |
| LifePoint, Inc. | -7.49 Million USD | 89.36% |
| Medite Cancer Diagnostics, Inc. | -6.48 Million USD | 87.693% |
| Paradigm Medical Industries, Inc. | 330 Thousand USD | 341.668% |
| QuantRx Biomedical Corporation | - USD | Infinity% |
| Remedent, Inc. | -122.89 Thousand USD | -548.958% |
| Reflect Scientific, Inc. | -467.27 Thousand USD | -70.67% |
| SmileDirectClub, Inc. | -241.15 Million USD | 99.669% |
| Sector 10, Inc. | -39.84 Thousand USD | -1901.566% |
| Shandong Weigao Group Medical Polymer Company Limited | 319.6 Million USD | 100.25% |
| SheerVision, Inc. | 155.72 Thousand USD | 612.12% |
| United Health Products, Inc. | -2.42 Million USD | 67.134% |
| Vasamed, Inc. | 4.74 Million USD | 116.817% |
| Wearable Health Solutions, Inc. | -2.29 Million USD | 65.237% |
| Yubo International Biotech Limited | -1.2 Million USD | 33.829% |